Shane McKenna is a Senior Principal Scientist at Bristol Myers Squibb, with extensive experience in chemical process development, particularly in drug development phases, biocatalysis, and outsourcing strategy. Previous roles include Senior Engineering and Chemistry Specialist at MSD, where compliance with regulatory requirements for process development was ensured, and Postdoctoral Research Associate at the University of Liverpool, focusing on enzyme immobilisation and oxidation optimization. Shane has a PhD in Chemistry from the University of Liverpool and a degree in Chemistry of Pharmaceutical Compounds from University College Cork. Additional experience encompasses roles in quality control at Pfizer and technical development at Genzyme, alongside a strong foundation in analytical techniques and laboratory procedures.
September, 2023 - present
January, 2021
September, 2020
January, 2018